newsfilter
← Latest News
GlobeNewswire·

UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of agilon health

  • Faruqi & Faruqi, LLP is investigating potential securities claims against agilon health, inc. (NYSE: AGL) with a March 2, 2026 deadline for investors to seek lead plaintiff status.
  • The lawsuit alleges defendants violated federal securities laws by issuing unrecoverable 2025 guidance, overstating financial impacts from strategic actions, and making misleading statements about business prospects.
  • On August 4, 2025, agilon health suspended its full-year 2025 financial guidance due to acute industry headwinds, causing its stock to fall 51.5% the following day.
  • Investors who purchased agilon health securities between February 26, 2025, and August 4, 2025, may contact partner Josh Wilson at 877-247-4292 or 212-983-9330 (Ext. 1310).
  • The firm invites whistleblowers, former employees, shareholders, and others with information regarding agilon health's conduct to reach out confidentially.
  • The putative class lead plaintiff will be the investor with the largest financial interest who directs the litigation, though absent class members retain the right to share in any recovery.